| |
|
|
|
|
| March 18,
2010 | ISSUE NUMBER 140 VOL 8 |
Strategy
Emerging Markets to Account for Half of Market Growth by 2013
A new report from IMS Health bumps the number of emerging markets to 17 and predicts that these nations will account for $90 billion in sales in the next four years. How will pharma take advantage of the opportunity?
Prescriptions
Rx Abandonment Rate Continues to Rise
The number of consumers ditching their drugs at the pharmacy keeps climbing as the economy worsens.
Sales Management
Reps Allowed Access; Just Make an Appointment
Physicians don’t seem to mind pharma sales reps dropping by—just make sure you make an appointment before you step through the door.
Guest Blog
Is There Life After Big Pharma?
Combined, the pharma and biopharma industries shed 58,969 jobs in the first nine months of 2009—15,000 more than the whole of 2008. In total, that makes around 74,000 redundancies in just 21 months, many but not all of which came from the sales force.
Call for Nominations
Pharmaceutical Executive¹s Emerging Pharma Leadership Award
The pharma industry is facing some tough times‹and the old way of doing things just won¹t work. So just who are the new leaders steering the industry though its most difficult challenges? Which executives are revamping the industry‹through pure innovation‹to remake it for the 21st century?
These emerging leaders are vital to the future of the industry, and you can help ensure that they get the recognition they deserve. Fill out your nomination today! |
|
Call for Nominations
Bold Brands Drive Revenue with Storytelling
By: Brian Schrack, Product Manager and Greg Flessing, President Powerful stories captivate us every day. NCM Fathom explores how businesses can drive revenue and build loyalty sharing their brand’s story to compel audiences to change behavior and take action.
Download the whitepaper.
|
 |
|  Bone Biologics added Mark Spilker to its board.
// Portola Pharmaceuticals upped William Lis from COO to CEO and appointed Hollings Renton co-chairman and lead director of the board.
// Pacific Biomarkers hired Jerri Hatch as associate director of business development.
// Endo Pharmaceuticals appointed Julie McHugh COO.
// GlaxoSmithKline appointed Jean Stephenne chairman of GSK Biologicals. He will keep his current post of president of GSK Biologicals.
// Organovo hired Marie Csete as EVP of R&D.
// Cylex hired Chari-Beth White as national sales manager and Julie Fudoli as business development manager, and promoted James Brosius to international manager, sales and marketing. //
|
Call for Nominations
9th Annual Forum on Patient Adherence, Compliance and Persistency
April 26 - 27, 2010 * Philadelphia, PA
Improve Product Utilization through Stakeholder Collaboration and Patient-Centered Initiatives
The program features varying perspectives from Pharma, Provider and Pharmacy on strategies for effective compliance partnerships. Don’t Miss the 5th Annual Strategic Patient Adherence (SPA) Awards - presented on-site at the conference!
For more information: visit
 www.cbinet.com/PatientCompliance or call 800-817-8601
|
|
|
|
 |
|
 |
|
 |
| Will open-source research and development have a positive effect on the industry? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe
from this list click
here.To
ensure delivery to your Inbox, please add %%email.list%% to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
